Neuphoria Therapeutics (NEUP) Cash & Equivalents (2020 - 2026)
Neuphoria Therapeutics (NEUP) reported Cash & Equivalents of $19.9 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 40.0% from $14.21 million a year earlier and up 2.4% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Cash & Equivalents (2020 - 2026) Analysis & Trends
Dating back to fiscal Q4 2020, Neuphoria Therapeutics' Cash & Equivalents record includes 16 quarters.
- Cash & Equivalents has increased for three consecutive fiscal years, though with a five-year compound annual growth rate of -1.9% (FY2021 to FY2026).
- By fiscal year, Cash & Equivalents came in at $14.21 million in FY2025 (+12.7%), $12.61 million in FY2024 (+4.2%), $12.1 million in FY2023 (-49.7%) and $24.04 million in FY2022 (+9.5%).
- Five-year quarterly Cash & Equivalents spans a low of $4.34 million in fiscal Q2 2025 and a high of $24.04 million in fiscal Q4 2022.
- Year over year, Cash & Equivalents has now increased in each of the last six quarters, with growth averaging 73.9% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was fiscal Q2 2026 (growth of 411.0%); the low point was fiscal Q2 2025 (a decline of 57.2%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $19.44 million (Q3 2026), $22.2 million (Q2 2026) and $13.65 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 19.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.90 Mn |
| Mar 31, 2026 | 19.44 Mn |
| Dec 31, 2025 | 22.20 Mn |
| Sep 30, 2025 | 13.65 Mn |
| Jun 30, 2025 | 14.21 Mn |
| Mar 31, 2025 | 17.04 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 8.08 Mn |
| Jun 30, 2024 | 12.61 Mn |
| Mar 31, 2024 | 8.43 Mn |
| Dec 31, 2023 | 10.15 Mn |
| Sep 30, 2023 | 8.14 Mn |
| Jun 30, 2023 | 12.20 Mn |
| Jun 30, 2022 | 24.04 Mn |
| Jun 30, 2021 | 21.95 Mn |
| Jun 30, 2020 | 3.00 Mn |
API Access
Neuphoria Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();